Atherosclerosis in chronic kidney disease: more, less, or just different?

JM Valdivielso, D Rodríguez-Puyol… - … , and vascular biology, 2019 - Am Heart Assoc
Patients with chronic kidney disease (CKD) are at an increased risk of premature mortality,
mainly from cardiovascular causes. The association between CKD on hemodialysis and …

Mechanisms of vascular calcification in kidney disease

S Disthabanchong, P Srisuwarn - Advances in chronic kidney disease, 2019 - Elsevier
The increase in prevalence and severity of vascular calcification in chronic kidney disease is
a result of complex interactions between changes in the vascular bed, mineral metabolites …

The Indian chronic kidney disease (ICKD) study: baseline characteristics

V Kumar, AK Yadav, J Sethi, A Ghosh… - Clinical kidney …, 2022 - academic.oup.com
Background Chronic kidney disease (CKD) is an important cause of morbidity and mortality
worldwide. There is a lack of information on epidemiology and progression of CKD in low …

Circulating angiotensin-converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular disease

L Anguiano, M Riera, J Pascual… - Nephrology Dialysis …, 2015 - academic.oup.com
Background Patients with cardiovascular (CV) disease have an increased circulating
angiotensin-converting enzyme 2 (ACE2) activity, but there is little information about …

Correlation between coronary artery disease with other arterial systems: similar, albeit separate, underlying pathophysiologic mechanisms

A Achim, OÁ Péter, M Cocoi, A Serban, S Mot… - Journal of …, 2023 - mdpi.com
Atherosclerosis is a multifactorial systemic disease that affects the entire arterial tree,
although some areas are more prone to lipid deposits than others. Moreover, the …

Predictors of subclinical atheromatosis progression over 2 years in patients with different stages of CKD

M Gracia, A Betriu, M Martinez-Alonso… - Clinical Journal of the …, 2016 - journals.lww.com
Results Prevalence of atheromatosis was 68.7% and progressed in 59.8% of patients after
24 months. CKD progression was associated with atheromatosis progression, suggesting a …

An in-depth analysis shows a hidden atherogenic lipoprotein profile in non-diabetic chronic kidney disease patients

M Bermudez-Lopez, C Forne, N Amigo… - Expert opinion on …, 2019 - Taylor & Francis
Background: Chronic kidney disease (CKD) is an independent risk factor for atherosclerotic
disease. We hypothesized that CKD promotes a proatherogenic lipid profile modifying …

Peritoneal Dialysis Aggravates and Accelerates Atherosclerosis in Uremic ApoE−/− Mice

J Kane, WG Vos, LA Bosmans, BW van Os… - Journal of the …, 2024 - ahajournals.org
Background Atherosclerosis is highly prevalent in people with chronic kidney disease
(CKD), including those receiving peritoneal dialysis (PD). Although it is lifesaving, PD …

New perspectives on CKD-induced dyslipidemia

M Bermúdez-López, D Arroyo, À Betriu… - Expert opinion on …, 2017 - Taylor & Francis
Introduction: Chronic kidney disease (CKD) is a world-wide health concern associated with
a significantly higher cardiovascular morbidity and mortality. One of the principal …

B-and T-lymphocyte attenuator could be a new player in accelerated atherosclerosis associated with chronic kidney disease

N Dolade, S Rayego-Mateos… - Clinical …, 2023 - portlandpress.com
Background: In chronic kidney disease (CKD), cardiovascular morbi-mortality is higher than
in general population. Atherosclerotic cardiovascular disease is accelerated in CKD, but …